Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Moxonidine for Hypertension in Young Obese Subjects
NCT01360710Phase 4Unknown
- Sponsor
- Baker Heart and Diabetes Institute
- Start
- Jan 2012
- Primary completion
- Jan 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of moxonidine in hypertension (HTN), sponsored by Baker Heart and Diabetes Institute. Status: unknown.
02
Drugs
moxonidine
03
Conditions
hypertension (HTN)
Beyond the preview
Go deeper on NCT01360710.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01360710.